Topic

Chris Spivey is the editorial director of 

Articles

Change of roster does not change the goal line. We are all patients first.

New Beginnings

Rita Peters is editorial director of Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.

While the players may change, pharma’s patients-first focus should not.

The Next Chapter

Editor of Pharmaceutical Technology Europe

Excessive drug pricing is being scrutinized across Europe, as hefty fines are set to send out a clear message of intolerance to anti-competition conduct.

Drug Pricing Scrutiny Increases in Europe

Podcasts

Pharmaceutical Technology discussed the potential increased risk of counterfeit medicines in the UK post-Brexit and how blockchain could be a useful tool to tackle the issue.

Tackling Counterfeit Medicines

The root cause of the most serious integrity issues has generally been a lapse of ethical behavior on the part of an individual. 

Viewpoint: Data Integrity and Its Ties with Personal Integrity

GSK’s position is raising concerns as it continues working towards its separation of businesses.

Divest and Conquer? GSK's Future is in Question

Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates. 

A “We are the World” Vaccination Effort?

Mike Hennessy, Sr., is the founder and chairman of MJH Life Sciences.

Technology advances foster new therapies.

From the Chairman: Technology Advances Foster New Therapies

As face masks start to come off, bio/pharma’s COVID-19 battle goes on.

Moving Into the Next Phase

The world of bio/pharma has been celebrating its achievements across a variety of categories in the latest rounds of awards.

Viewpoints